Printer Friendly

VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK

    VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH
              SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
    CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that it intends to file on Tuesday, Nov. 12th, a Registration Statement with the Securities and Exchange Commission relating to a public offering by the company of 2 million shares of its common stock.
    Of the shares to be offered for sale, 1.6 million shares will be offered in the United States, and 400,000 shares will be offered in a concurrent international offering outside the United States.  Vertex Pharmaceuticals will grant to the underwriters in the U.S. offering an option to purchase up to 300,000 shares of common stock solely to cover over-allotments, if any.
    -0-                    11/11/91
    /CONTACT: Richard Aldrich, vice president of Vertex, 617-576-3111; or Robert Gottlieb of Feinstein Partners, 617-577-8110, for Vertex/
    (VRTX) CO:  Vertex Pharmaceuticals Inc. ST:  Massachusetts IN:  MTC SU: DD-KM -- NE009 -- 3142 11/11/91 16:10 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 11, 1991
Words:168
Previous Article:NEORX ANNOUNCES FOURTH QUARTER FINANCIAL RESULTS
Next Article:NWNL COMPANIES STRENGTHENS BALANCE SHEET IN THIRD QUARTER AND OPERATIONS REMAIN STRONG; NET INCOME IS $11.9 MILLION
Topics:


Related Articles
VERTEX PHARMACEUTICALS FILES REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS FILES REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS FILES REGISTRATION STATEMENT WITH SEC TO SELL 2,500,000 SHARES OF COMMON STOCK
Vertex Pharmaceuticals Files Registration Statement with SEC to Sell 2,500,000 Shares of Common Stock
Vertex Pharmaceuticals Announces $200 Million Private Offering Of Convertible Subordinated Notes.
Vertex Pharmaceuticals Raises $300 Million in Convertible Subordinated Debt Placement.
Vertex Pharmaceuticals Announces Exercise of Overallotment by Underwriters.
Vertex Pharmaceuticals Announces Proposed Public Offering of Common Stock.
Vertex Pharmaceuticals Announces Pricing of Common Stock Offering.
Vertex Pharmaceuticals Announces Completion of Common Stock Offering.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters